Pathophysiology of neoplasic cachexia;Fisiopatología de la caquexia neoplásica

Nutricion Hospitalaria

Volumn 21, Issue SUPPL. 3, 2006, Pages 4-9

  Argiles J M ^a   Busquets, S ^a   Lopez Soriano F J ^a   Figueras, M ^a  

^a UNIVERSITY OF BARCELONA   (Spain)

Author keywords

Cachexia; Cancer; Cytokines; Muscle proteolysis; Physiopathology

Indexed keywords

ANOREXIA; CACHEXIA; CANCER; CHEMOTHERAPY; FOOD INTAKE; HUMAN; IMMUNOTHERAPY; MALNUTRITION; METABOLIC DISORDER; PATHOPHYSIOLOGY; PROTEIN DEGRADATION; PSYCHOLOGICAL ASPECT; REVIEW; WEIGHT REDUCTION;

CACHEXIA; HUMANS; NEOPLASMS;

EID: 33745088891     PISSN: 02121611     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (16)

1. Evans RD, Argilés JM, Williamson DH: Metabolic effects of tumour necrosis factor-alpha (cachectin) and interleukin-1. Clin Sci 1989; 77:357-64.
2. Argilés JM, García-Martínez C, Llovera M, López-Soriano FJ: The role of cytokines in muscle wasting: its relation with cancer cachexia. Med Res Rev 1992; 12:637-52.
3. Beutler BA, Milsark IW, Cerami A: Cachectin/tumor necrosis factor: production, distribution, and metabolic fate in vivo. J Immunol 1985; 135:3972-7.
4. Oliff A, Defeo-Jones D, Boyer M, Martínez D, Kiefer D, Vuocolo G y cols.: Tumors secreting human TNF/cachectin induce cachexia in mice. Cell 1987; 50:555-63.
5. García-Martínez C, Costelli P, López-Soriano FJ, Argilés JM: Is TNF really involved in cachexia? Cancer Invest 1997; 15:47-54.
6. Argilés JM, López-Soriano J, Busquets S, López-Soriano FJ: Journey from cachexia to obesity by TNF. FASEB J 1997; 11:743-51.
7. Costelli P, Carbó N, Tessitore L, Bagby GJ, López-Soriano FJ, Argilés JM y cols.: Tumor necrosis factor-alpha mediates changes in tissue protein turnover in a rat cancer cachexia model. J Clin Invest 1993; 92:2783-9.
8. Argilés JM, López-Soriano FJ: The ubiquitin-dependent proteolytic pathway in skeletal muscle: its role in pathological states. Trends Pharmacol Sci 1996; 17:223-6.
9. Van Royen M, Carbó N, Busquets S, Alvarez B, Quinn LS, López-Soriano FJ y cols.: DNA fragmentation occurs in skeletal muscle during tumor growth: a link with cancer cachexia. Biochem. Biophys Res Commun 2000; 270:533-7.
10. Carbó N, Busquets S, van Royen M, Alvarez B, López-Soriano FJ, Argilés JM: TNF-alpha is involved in activating DNA fragmentation in skeletal muscle. Br J Cancer 2002; 86:1012-6.
11. Sanchís D, Busquets S, Álvarez B, Ricquier D, López-Soriano FJ, Argilés JM: Skeletal muscle UCP2 and UCP3 gene expression in a rat cancer cachexia model. FEBS Lett 1998; 436:415-8.
12. Busquets S, Sanchís D, Álvarez B, Ricquier D, López-Soriano FJ, Argilés JM: In the rat, tumor necrosis factor alpha administration results in an increase in both UCP2 and UCP3 mRNAs in skeletal muscle: a possible mechanism for cytokine-induced thermogenesis? FEBS Lett 1998; 440:348-50.
13. Busquets S, Aranda X, Ribas-Carbó M, Azcón-Bieto J, López-Soriano FJ, Argilés JM: Tumour necrosis factor-alpha uncouples respiration in isolated rat mitochondria. Cytokine 2003; 22:1-4.
14. Argilés JM, Álvarez B, López-Soriano FJ: The metabolic basis of cancer cachexia. Med Res Rev 1997; 17:477-98.
15. Hirai K, Ishiko O, Tisdale M: Mechanism of depletion of liver glycogen in cancer cachexia. Biochem Biophys Res Commun 1997; 241:49-52.
16. Todorov PT, Field WN, Tisdale MJ: Role of a proteolysis-inducing factor (PIF) in cachexia induced by a human melanoma (G361). Br J Cancer 1999; 80:1734-7.